The Hereditary Angioedema Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Hereditary Angioedema Market?
The market size of the hereditary angioedema has seen considerable growth in the past few years. The market size will increase from $2.62 billion in 2024 to $2.84 billion in 2025, growing at a compound annual growth rate (CAGR) of 8.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Hereditary Angioedema Industry?
The hereditary angioedema market is projected to reach $3.93 billion in 2029, with a compound annual growth rate (CAGR) of 8.4%.
Download Your Free Sample of the 2025 Hereditary Angioedema Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Hereditary Angioedema Market?
The key drivers in the hereditary angioedema market are:
• Rising prevalence of rare diseases
• Increasing medical expenditure
• Growing support from non-profit organizations
• Rising awareness about earlier diagnoses of hereditary angioedema
Global Market Segmentation: Identifying Major Hereditary Angioedema Industry Segments
The hereditary angioedema market covered in this report is segmented –
1) By Type: Hereditary Angioedema Type I, Hereditary Angioedema Type II
2) By Treatment Type: Prophylaxis, On-demand
3) By Drug Class: C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors, Other Drug Classes
4) By Route Of Administration: Subcutaneous, Intravenous, Oral
5) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Hereditary Angioedema Type I: C1-Inhibitor Deficiency, Low C1-Inhibitor Levels, Reduced C1-Inhibitor Function
2) By Hereditary Angioedema Type II: Normal C1-Inhibitor Levels, Dysfunctional C1-Inhibitor, Genetic Mutations In SERPING1 Gene
Pre-order the 2025 Hereditary Angioedema Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Hereditary Angioedema Market?
The key trends in the hereditary angioedema market are:
• Technological advancements are playing a significant role in shaping the future of the market.
• The development of novel therapies is emerging as an important trend.
• The launch of new pharmaceutical products is a key upcoming trend.
• There is increasing usage of advanced diagnostic tools and advancements in genetic testing.
Who Are the Top Competitors & Leading Players in the Hereditary Angioedema Market?
Major players in the hereditary angioedema market are:
• Intellia Therapeutics Inc.
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited
• Otsuka Pharmaceutical Co. Ltd.
• CSL Limited
• Cipla Limited
• BioMarin Pharmaceutical Inc.
• Ionis Pharmaceuticals Inc.
• BioCryst Pharmaceuticals Inc.
• Arrowhead Pharmaceuticals Inc.
• Spark Therapeutics Inc.
• Pharming Group N.V.
• Pharvaris N.V.
• Astria Therapeutics Inc.
• CENTOGENE N.V.
• KalVista Pharmaceuticals Inc.
• ADARx Pharmaceuticals Inc.
• Adverum Biotechnologies Inc.
• Attune Pharmaceuticals Inc.
• Lev Pharmaceuticals Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the hereditary angioedema market in 2024
